心脉医疗收盘下跌1.37%，滚动市盈率30.82倍，总市值137.92亿元

Company Overview - Shanghai MicroPort CardioFlow Medtech Co., Ltd. specializes in the research, production, and sales of interventional medical devices for aortic and peripheral vascular applications [2] - The main products include thoracic aortic stent graft systems, abdominal aortic stent graft systems, intraoperative stents, balloon catheters, and stents [2] - The company has received several accolades, including the Shanghai Government Quality Gold Award and recognition as one of the top 30 value companies on the Sci-Tech Innovation Board [2] Financial Performance - For Q1 2025, the company reported revenue of 332 million yuan, a year-on-year decrease of 7.23% [2] - The net profit for the same period was 130 million yuan, down 29.66% year-on-year, with a gross profit margin of 69.61% [2] Market Position - As of August 5, the company's stock closed at 111.89 yuan, down 1.37%, with a rolling PE ratio of 30.82 times [1] - The average PE ratio for the medical device industry is 54.24 times, with a median of 37.92 times, placing the company at 61st in industry rankings [1][3] Shareholder Information - As of March 31, 2025, the number of shareholders increased to 18,176, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1]